ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 601679 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 601679; 2) Community: the network communities that were significantly associated with the response to NSC 601679; 3) Molecule: the relationships between components within communities and NSC 601679; 4) MDR: the compounds that were significantly associated with the NSC 601679.

NSC Compound Enrichment Correlation
NSC 116878 Cardiac glycoside 0.0133299224082802 -0.10005385
NSC 130862 Null 0.0133299224082802 0.30793719
NSC 154829 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamidoxime, 4-(hydroxyamino)-7-.beta.-D-ribofuranosyl-, monohydrochloride 0.0133299224082802 -0.048816987
NSC 15812 Null 0.0133299224082802 0.2353943
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0133299224082802 0.20191835
NSC 176327 Ellipticine, 6-(3-aminopropyl)-9-methoxy-, dihydrochloride 0.0133299224082802 0.19097983
NSC 184692 Aminopterin Derivative 0.0133299224082802 0.12749524
NSC 243022 Cinerubin A hydrochloride 0.0133299224082802 0.36099226
NSC 250682 Oridonin 0.0133299224082802 0.11357337
NSC 274548 Gold, [.mu.-[[5,5'-methylenebis[1H-tetrazolato]](2-)-N(1):N(1')]]bis(triphenylphosphine)di- 0.0133299224082802 0.11729843
Total:116  Current:43    [First] [Prev] [Next] [Last]